Hepatitis C Viral Replication Complex
The life cycle of the hepatitis C virus (HCV) can be divided into several stages, including viral entry, protein translation, RNA replication, viral assembly, and release. HCV genomic RNA replication occurs in the replication organelles (RO) and is tightly linked to ER membrane alterations containin...
| Published in: | Viruses |
|---|---|
| Main Authors: | Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-03-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/13/3/520 |
Similar Items
Membrane Retention of West Nile Virus NS5 Depends on NS1 or NS3 for Enzymatic Activity
by: Alanna C. Tseng, et al.
Published: (2024-08-01)
by: Alanna C. Tseng, et al.
Published: (2024-08-01)
NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)
Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil
by: Elisabete Andrade, et al.
Published: (2020-02-01)
by: Elisabete Andrade, et al.
Published: (2020-02-01)
Emerging therapies for the treatment of hepatitis C
by: Christian M Lange, et al.
Published: (2013-09-01)
by: Christian M Lange, et al.
Published: (2013-09-01)
The Japanese encephalitis virus NS1 protein concentrates ER membranes in a cytoskeleton-independent manner to facilitate viral replication
by: Shengda Xie, et al.
Published: (2025-03-01)
by: Shengda Xie, et al.
Published: (2025-03-01)
The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein
by: Clément Mazeaud, et al.
Published: (2021-10-01)
by: Clément Mazeaud, et al.
Published: (2021-10-01)
Novel Thiazolidinedione Derivatives as Potential ZIKV Antiviral Inhibitors
by: Isabella Luiza Ralph de Oliveira, et al.
Published: (2025-08-01)
by: Isabella Luiza Ralph de Oliveira, et al.
Published: (2025-08-01)
Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugs
by: Allan Peres-da-Silva, et al.
Published: (2012-03-01)
by: Allan Peres-da-Silva, et al.
Published: (2012-03-01)
Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
by: Jenny Kouretova, et al.
Published: (2017-01-01)
by: Jenny Kouretova, et al.
Published: (2017-01-01)
Comparative Analysis of Hepatitis C Virus NS5A Dynamics and Localization in Assembly-Deficient Mutants
by: Laura Riva, et al.
Published: (2021-02-01)
by: Laura Riva, et al.
Published: (2021-02-01)
The Role of the Flavivirus Replicase in Viral Diversity and Adaptation
by: Haley S. Caldwell, et al.
Published: (2022-05-01)
by: Haley S. Caldwell, et al.
Published: (2022-05-01)
The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage
by: Ching-Lin Lin, et al.
Published: (2023-10-01)
by: Ching-Lin Lin, et al.
Published: (2023-10-01)
Factors Influencing the Prevalence of Resistance-Associated Substitutions in NS5A Protein in Treatment-Naive Patients with Chronic Hepatitis C
by: Karen K. Kyuregyan, et al.
Published: (2020-04-01)
by: Karen K. Kyuregyan, et al.
Published: (2020-04-01)
The ACBD3 protein coordinates ER-Golgi contacts to enable productive TBEV infection
by: Wai-Lok Yau, et al.
Published: (2025-05-01)
by: Wai-Lok Yau, et al.
Published: (2025-05-01)
MARCH6 suppresses Tembusu virus replication by targeting viral NS5 protein for TOLLIP-mediated selective autophagic degradation
by: Peng Zhou, et al.
Published: (2025-07-01)
by: Peng Zhou, et al.
Published: (2025-07-01)
Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
by: Jeong Heo, et al.
Published: (2023-07-01)
by: Jeong Heo, et al.
Published: (2023-07-01)
The glycosylation deficiency of flavivirus NS1 attenuates virus replication through interfering with the formation of viral replication compartments
by: Shuhan Huang, et al.
Published: (2024-06-01)
by: Shuhan Huang, et al.
Published: (2024-06-01)
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
by: Harun Norshidah, et al.
Published: (2021-11-01)
by: Harun Norshidah, et al.
Published: (2021-11-01)
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
by: Harun Norshidah, et al.
Published: (2023-02-01)
by: Harun Norshidah, et al.
Published: (2023-02-01)
Interaction of West Nile virus NS5 with orthoflavivirus SLA RNAs and their effects on viral replication and inhibition
by: Mandi A. Feinberg, et al.
Published: (2025-09-01)
by: Mandi A. Feinberg, et al.
Published: (2025-09-01)
A Fluorescent Cell-Based System for Imaging Zika Virus Infection in Real-Time
by: Michael J. McFadden, et al.
Published: (2018-02-01)
by: Michael J. McFadden, et al.
Published: (2018-02-01)
Potential Dual Role of West Nile Virus NS2B in Orchestrating NS3 Enzymatic Activity in Viral Replication
by: Alanna C. Tseng, et al.
Published: (2021-01-01)
by: Alanna C. Tseng, et al.
Published: (2021-01-01)
Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis
by: Hui-Chun Li, et al.
Published: (2022-08-01)
by: Hui-Chun Li, et al.
Published: (2022-08-01)
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection
by: Fabien Zoulim, et al.
Published: (2018-01-01)
by: Fabien Zoulim, et al.
Published: (2018-01-01)
Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia
by: Naohiro Noda, et al.
Published: (2012-03-01)
by: Naohiro Noda, et al.
Published: (2012-03-01)
Erp57 facilitates ZIKV-induced DNA damage via NS2B/NS3 complex formation
by: Yiran Wang, et al.
Published: (2024-12-01)
by: Yiran Wang, et al.
Published: (2024-12-01)
Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates
by: Jaspe Rossana C, et al.
Published: (2012-09-01)
by: Jaspe Rossana C, et al.
Published: (2012-09-01)
Interferon-stimulated gene 15 facilitates BTV replication through interacting with the NS1 protein
by: Di Kang, et al.
Published: (2023-08-01)
by: Di Kang, et al.
Published: (2023-08-01)
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
by: Marta Celegato, et al.
Published: (2023-02-01)
by: Marta Celegato, et al.
Published: (2023-02-01)
Methotrexate, an anti-inflammatory drug, inhibits Hepatitis E viral replication
by: Akash Kumar, et al.
Published: (2023-12-01)
by: Akash Kumar, et al.
Published: (2023-12-01)
Corrigendum: Advancement in the development of therapeutics against Zika virus infection
by: Kangchen Li, et al.
Published: (2022-08-01)
by: Kangchen Li, et al.
Published: (2022-08-01)
Genetic variability in the 5' UTR and NS5A regions of hepatitis C virus RNA isolated from non-responding and responding patients with chronic HCV genotype 1 infection
by: Flávio MG Araújo, et al.
Published: (2008-09-01)
by: Flávio MG Araújo, et al.
Published: (2008-09-01)
Association of multiple mutations in NS5A and NS5B genes and resistance to direct-acting antivirals in chronically infected Egyptian patients with Hepatitis C virus Genotype 4a
by: Gehad M. Mohamed, et al.
Published: (2024-02-01)
by: Gehad M. Mohamed, et al.
Published: (2024-02-01)
Paritaprevir as a pan-antiviral against different flaviviruses
by: R. P. Yadav, et al.
Published: (2025-04-01)
by: R. P. Yadav, et al.
Published: (2025-04-01)
Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti
by: Daniel Chieh-Ding Lin, et al.
Published: (2023-05-01)
by: Daniel Chieh-Ding Lin, et al.
Published: (2023-05-01)
Discovery of Bispecific Lead Compounds from <i>Azadirachta indica</i> against ZIKA NS2B-NS3 Protease and NS5 RNA Dependent RNA Polymerase Using Molecular Simulations
by: Sanjay Kumar, et al.
Published: (2022-04-01)
by: Sanjay Kumar, et al.
Published: (2022-04-01)
Hepatitis C Virus and Hepatitis B Virus Co-Infection
by: Yi-Fen Shih, et al.
Published: (2020-07-01)
by: Yi-Fen Shih, et al.
Published: (2020-07-01)
Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals
by: Alejandra Álvarez-Mínguez, et al.
Published: (2024-01-01)
by: Alejandra Álvarez-Mínguez, et al.
Published: (2024-01-01)
Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review
by: Abdul Wahaab, et al.
Published: (2021-12-01)
by: Abdul Wahaab, et al.
Published: (2021-12-01)
Construction of a Recombinant Japanese Encephalitis Virus with a Hemagglutinin-Tagged NS2A: A Model for an Analysis of Biological Characteristics and Functions of NS2A during Viral Infection
by: Xiaochun Ma, et al.
Published: (2022-03-01)
by: Xiaochun Ma, et al.
Published: (2022-03-01)
Similar Items
-
Membrane Retention of West Nile Virus NS5 Depends on NS1 or NS3 for Enzymatic Activity
by: Alanna C. Tseng, et al.
Published: (2024-08-01) -
NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01) -
Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil
by: Elisabete Andrade, et al.
Published: (2020-02-01) -
Emerging therapies for the treatment of hepatitis C
by: Christian M Lange, et al.
Published: (2013-09-01) -
The Japanese encephalitis virus NS1 protein concentrates ER membranes in a cytoskeleton-independent manner to facilitate viral replication
by: Shengda Xie, et al.
Published: (2025-03-01)
